Cambridge Biomedical Announces Addition of Video Production to Its Range of CRO Services

Cambridge Biomedical is excited to add video production services to its range of offerings. Targeted at streamlining the clinical trial sample collection process and reducing error rates.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Reduce clinical trial sample error rates using video training.

Boston, MA (PRWEB) June 18, 2014

Cambridge Biomedical is excited to add video production services to its range of offerings.

This addition is targeted at streamlining the sample collection process for clinical trials and assisting in ensuring sample preparation consistency between collection sites. Frequently, the main source of error in clinical trials is coordinating sample collection, preparation, labeling, handling and shipment. By providing a concise video of the process, tailored to the clients specific requirements, we have found a dramatic reduction in the occurrence of errors.

Adding this video service in conjunction with Cambridge Biomedical’s experience with bioanalytical assay development, optimization, validation and diagnostic testing has proved instrumental in assisting biotechnology and pharmaceutical companies that are focusing on expediting their development programs.

We will be exhibiting at BIO 2014 in San Diego, please visit us at booth #5604 for more information.

Cambridge Biomedical
Since 1997, Cambridge Biomedical has partnered with our clients by providing a diverse range of services from pre-clinical to post market. Including; assay development, optimization, validation and diagnostic testing. Conveniently located to support the Northeast pharmaceutical development market, yet with a national and global reach. Our personalized project management, approach along with a focus on delivering quality results and regulatory submission ready documentation and rapid turnaround times, ensure we meet our client’s product development timelines.


Contact

Follow us on: Contact's Google Plus